Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

University of Alberta

$70,000.00

Improving Outcomes in First Episode Psychosis: the Role of Genetic Variation of NPAS3

FY 2010-11

Summary
Schizophrenia (SZ) is a complex psychiatric disorder with an incidence of 1% worldwide. SZ has a strong genetic component. Symptoms of SZ include hallucinations, delusions, impaired emotional processing and disorganization of thought and speech. To date no single "SZ gene" has been identified; rather, multiple genes have been implicated in SZ, but not all of these genes are altered in all SZ patients. It is important to identify the specific effects of each candidate gene in the pathology of the overall disease. NPAS3 was identified as a SZ candidate gene in a family where a chromosomal rearrangement lead to a break in the NPAS3 gene only found in individuals with SZ. NPAS3 variants have also been identified in multiple association studies of SZ. NPAS3 encodes a transcription factor expressed in the developing mouse central nervous system and neuronal stem cells of the hippocampus of adult mouse brains. These cells are important in social learning and memory, both found to be deficient in SZ patients. Our team is working with a normal population of high school students to determine the effects of known SZ-associated variants of NPAS3 which, when independent of other SZ variants in other genes, don't cause disease (known as an endophenotype). Recruited students undergo genetic analysis, tests of cognition and MRI analysis of brain structure. We will also undertake molecular analysis of NPAS3 to determine its molecular functions. We will determine its localization in the cell, its stability, and the genes regulated by NPAS3. Variant forms of NPAS3 will be analyzed to determine how their function varies compared with normal NPAS3 to possibly explain the cognitive and structural endophenotypes observed in the normal high school student population. Through our studies we will identify the specific role that variant NPAS3 plays in development and onset of SZ. This will allow streamlining of therapies allowing more targeted therapy for individuals who carry NPAS3 variants.
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
229688
Name
Luoma Leiah M
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Improving Outcomes in First Episode Psychosis: the Role of Genetic Variation of NPAS3
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$70,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Assessment Of Transcription Factor Function; Chromatin Immunoprecipitation; Cognitive Assessment; Molecular Analysis Of Gene Regulation; Mri Analysis; Neurodevelopment; Psychiatric Genetics
Abstract
Schizophrenia (SZ) is a complex psychiatric disorder with an incidence of 1% worldwide. SZ has a strong genetic component. Symptoms of SZ include hallucinations, delusions, impaired emotional processing and disorganization of thought and speech. To date no single "SZ gene" has been identified; rather, multiple genes have been implicated in SZ, but not all of these genes are altered in all SZ patients. It is important to identify the specific effects of each candidate gene in the pathology of the overall disease. NPAS3 was identified as a SZ candidate gene in a family where a chromosomal rearrangement lead to a break in the NPAS3 gene only found in individuals with SZ. NPAS3 variants have also been identified in multiple association studies of SZ. NPAS3 encodes a transcription factor expressed in the developing mouse central nervous system and neuronal stem cells of the hippocampus of adult mouse brains. These cells are important in social learning and memory, both found to be deficient in SZ patients. Our team is working with a normal population of high school students to determine the effects of known SZ-associated variants of NPAS3 which, when independent of other SZ variants in other genes, don't cause disease (known as an endophenotype). Recruited students undergo genetic analysis, tests of cognition and MRI analysis of brain structure. We will also undertake molecular analysis of NPAS3 to determine its molecular functions. We will determine its localization in the cell, its stability, and the genes regulated by NPAS3. Variant forms of NPAS3 will be analyzed to determine how their function varies compared with normal NPAS3 to possibly explain the cognitive and structural endophenotypes observed in the normal high school student population. Through our studies we will identify the specific role that variant NPAS3 plays in development and onset of SZ. This will allow streamlining of therapies allowing more targeted therapy for individuals who carry NPAS3 variants.
Competitiondate
201010
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Luoma, Leiah M
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $70,000~ $0~
University of Alberta - $70,000 Grant (2010-11) | Canada Spends